It is a good product, just too expensive and needs to be taken on by Medicare?
- Forums
- ASX - By Stock
- Ann: Regeneus Appoints International Directors for Global Growth
It is a good product, just too expensive and needs to be taken...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
(20min delay)
|
|||||
Last
42.5¢ |
Change
0.010(2.41%) |
Mkt cap ! $5.070M |
Open | High | Low | Value | Volume |
42.5¢ | 43.0¢ | 42.5¢ | $130 | 306 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3205 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 24 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3205 | 0.425 |
1 | 20000 | 0.420 |
1 | 370 | 0.410 |
1 | 400 | 0.400 |
1 | 6000 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 24 | 1 |
0.500 | 334 | 1 |
0.545 | 400 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 13.20pm 12/11/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online